Lymphoseek

Navidea stock jumps 76% after agreeing to $80 million Cardinal Health deal
Marketwatch
Tue, 09/6/16 - 09:52 am
Navidea Biopharmaceuticals
Cardinal Health
Lymphoseek
M&A
FDA approves expanded label for Lymphoseek
Seeking Alpha
Wed, 10/15/14 - 08:10 am
FDA
Lymphoseek
Navidea Biopharmaceuticals
Navidea drops after FDA nod for drug used in cancer patients
Fierce Biotech
Thu, 03/14/13 - 11:39 am
Navidea Biopharmaceuticals
FDA
breast cancer
Lymphoseek
Tackling Cancer: Breast Cancer's Biggest Current & Upcoming Players
Motley Fool
Tue, 03/12/13 - 05:36 pm
breast cancer
aromatase inhibitors
AstraZeneca
Novartis
Femara
Arimidex
SERMs
Nolvadex
Roche
Herceptin
GSK
Tykerb
Xeloda
Perjeta
Kadcyla
Immunogen
Lymphoseek
Navidea Biopharmaceuticals
Nexavar
ONYX Pharmaceuticals
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
FDA
drug approvals
Roche
T-DM1
Aveo
Delcath
Navidea Biopharmaceuticals
Lymphoseek
tivozanib
chemostat
Navidea Biopharmaceuticals Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission
Tue, 11/13/12 - 10:21 pm
Navidea Biopharmaceuticals
Lymphoseek
Navidea Biopharmaceuticals Resubmits New Drug Application for Lymphoseek® to FDA
Wed, 10/31/12 - 10:56 pm
Navidea Biopharmaceuticals
Lymphoseek
FDA
Navidea Biopharmaceuticals Posts Lymphoseek® NDA Update to Company Website
Wed, 10/10/12 - 07:46 pm
Navidea Biopharmaceuticals
NDA
Lymphoseek
Lymphoseek: No Quick Approval Here
Motley Fool
Wed, 09/26/12 - 11:13 am
Lymphoseek
Navidea Biopharmaceuticals
PropThink:NAVB To Meet With FDA, Lymphoseek Approval By Year-End Possible
Tue, 09/25/12 - 09:16 pm
FDA
Lymphoseek
Navidea regroups after FDA delays future pharmaceutical sales of cancer imaging agent
Medreps.com
Wed, 09/12/12 - 12:23 pm
Navidea
FDA
Lymphoseek
Navidea slumps as FDA doesn't approve Lymphoseek
Tue, 09/11/12 - 10:48 pm
Navidea
FDA
Lymphoseek
Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville
Tue, 09/4/12 - 12:27 pm
Gilead
Salix
Peregrine Pharmaceuticals
Navidea Biopharmaceuticals
Crofelemer
tobramycin
Lymphoseek
bavituximab
Truvada
Eylea
Regeneron
lixivaptan
Cornerstone Therapeutics
Neoprobe executives plan stock sell-off if FDA green-lights Lymphoseek
Sat, 09/24/11 - 03:28 pm
Neoprobe
FDA
Lymphoseek
Neoprobe presses past controversy, submits Lymphoseek NDA| Regulatory Roundup
Thu, 08/11/11 - 11:06 pm
Neoprobe
Lymphoseek
regulatory
Neoprobe Submits New Drug Application for Lymphoseek
Wed, 08/10/11 - 04:21 pm
Neoprobe
Drug
Lymphoseek
A Drugmaker, A Short Seller & A Citizen’s Petition
Pharmalot
Thu, 06/16/11 - 11:40 am
FDA
Neoprobe
Lymphoseek
Neoprobe Announces 2010 Results with Record Medical Device Sales
Mon, 03/7/11 - 12:06 pm
Neoprobe
revenues
earnings
Lymphoseek
Neoprobe partners with Ohio organizations to market cancer drug
Sat, 06/19/10 - 11:23 am
Neoprobe
Lymphoseek
radiopharmaceuticals
breast cancer
melanoma